Oxaliplatin-induced damage of cellular DNA

Molecular Pharmacology

Volumn 58, Issue 5, 2000, Pages 920-927

  Woynarowski, Jan M ^a   Faivre, Sandrine ^a,d   Herzig, Maryanne C S ^a   Arnett, Brenda ^a   Chapman, William G ^a   Trevino, Alex V ^a   Raymond, Eric ^a   Chaney, Stephen G ^b   Vaisman, Alexandra ^b   Varchenko, Maria ^b   Juniewicz, Paul E ^c  

^a CTRC Institute for Drug Development   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Biostatistics   (United States)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CISPLATIN; CYCLOHEXYLAMINE DERIVATIVE; OXALIPLATIN; PLATINUM DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; COLON ADENOCARCINOMA; CONTROLLED STUDY; DNA ADDUCT; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS; DRUG CYTOTOXICITY; DRUG DNA INTERACTION; DRUG MECHANISM; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKEMIA CELL LINE; OVARY CARCINOMA; PLASMID; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; T CELL LEUKEMIA;

EID: 0033789184     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.5.920     Document Type: Article

References (42)

1. Loss of DNA mismatch repair in acquired resistance to cisplatin
2. The number of platinum atoms binding to DNA. RNA and protein molecules of HeLa cells treated with cisplatin at its mean lethal concentration
3. Binding characteristics of (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-2-pla in um(II) to DNA, RNA and protein molecules in HeLa cells and its lethal effect: Comparison with cis- and trans-diamminedichloroplatinums(II)
4. Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases alpha and beta, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy
5. Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloroplatinum(II)
6. The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand (review)
7. Enhanced host cell reactivation of damaged plasmid DNA in HeLa cells resistant to cis-diamminedichloroplatinu-m(II)
8. Ongoing and unsaid on oxaliplatin: The hope
9. Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines
10. Oxaliplatin effects on DNA integrity and apoptosis induction in human tumor cells, in Proceedings of the Annual Meeting of the American Association of Cancer Research, vol 39, p 158; 1998 Mar 25-Apr 1; New Orleans
11. Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cells
12. The role of DNA mismatch repair in platinum drug resistance
13. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
14. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells
15. Role of carrier ligand in platinum resistance in L1210 cells
16. Enhancement of excision repair of cisplatin-DNA adducts by cell-free extract from a cisplatin-resistant rat cell line
17. New platinum agents: A comparison in ovarian cancer
18. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours
19. Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cells
20. Biotransformations of oxaliplatin in rat blood in vitro
21. High-performance liquid chromatographic separation of the biotransformation products of oxaliplatin
22. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines
23. Induction of JNK and c-Abl signalling by cisplatin and oxahplatin in mismatch repair-proficient and -deficient cells
24. Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier hgand specificity
25. Oxaliplatin: Mechanism of action and antineoplastic activity (review)
26. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and bis-aceto-ammine-dichlorocyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts
27. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel
28. The frequency of interstrand cress-links in DNA following reaction of cis-diamminechloroplatinum(II) with cells in culture or DNA in vitro: Stability of DNA crosslinks and their repair
29. Quantitative estimation of cisplatin-induced DNA interstrand cress-links and their repair in mammalian cells: Relationship to toxicity
30. The role of platinum-DNA interactions in the cellular toxicity and anti-tumour effects of platinum co-ordination compounds
31. Mutagenic and carcinogenic properties of platinum-based anticancer drugs
32. In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells
33. Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatin
34. Role of carrier ligand in platinum resistance of human carcinoma cell lines
35. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: Correlation with replicative bypass of platinum-DNA adducts
36. New cisplatin analogues in development: A review
37. Induction of AT-specific DNA-interstrand crosslinks by bizelesin in genomic and simian virus 40 DNA
38. Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA
39. Effects of bizelesin (U-77779), bifunctional akylating minor groove agent, on genomic and simian virus 40 DNA
40. Induction of DNA-protein crosslinks by antitumor 1-nitro-9-aminoacridines in L1210 leukemia cells
41. Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene, 6-hydroxymethylacylfulvene (HMAF MGI 114)
42. Topoisomerase II-mediated lesions in nascent DNA: Comparison of the effects of epipodophyllotoxin derivatives VM-26, and VP-16, and 9-anihnoacridine derivative, m-AMSA and o-AMSA